Chen C - Search Results

1

The prognostic value of quantitative analysis of CCL5 and collagen IV in luminal B (HER2-) subtype breast cancer by quantum-dot-based molecular imaging.

Zhu YY, Chen C, Li JJ, Sun SR. Zhu YY, et al. Among authors: chen c. Int J Nanomedicine. 2018 Jun 28;13:3795-3803. doi: 10.2147/IJN.S159585. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29988769 Free PMC article.

2

Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer.

Chen C, Peng J, Xia HS, Yang GF, Wu QS, Chen LD, Zeng LB, Zhang ZL, Pang DW, Li Y. Chen C, et al. Among authors: chen ld. Biomaterials. 2009 May;30(15):2912-8. doi: 10.1016/j.biomaterials.2009.02.010. Epub 2009 Feb 28. Biomaterials. 2009. PMID: 19251316

3

Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity.

Chen C, Peng J, Xia H, Wu Q, Zeng L, Xu H, Tang H, Zhang Z, Zhu X, Pang D, Li Y. Chen C, et al. Nanotechnology. 2010 Mar 5;21(9):095101. doi: 10.1088/0957-4484/21/9/095101. Epub 2010 Jan 29. Nanotechnology. 2010. PMID: 20110584

4

The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis.

Chen C, Xia HS, Gong YP, Peng J, Peng CW, Hu MB, Zhu XB, Pang DW, Sun SR, Li Y. Chen C, et al. Biomaterials. 2010 Nov;31(33):8818-25. doi: 10.1016/j.biomaterials.2010.07.091. Epub 2010 Aug 17. Biomaterials. 2010. PMID: 20723971

5

Quantum dots-based double-color imaging of HER2 positive breast cancer invasion.

Liu XL, Peng CW, Chen C, Yang XQ, Hu MB, Xia HS, Liu SP, Pang DW, Li Y. Liu XL, et al. Among authors: chen c. Biochem Biophys Res Commun. 2011 Jun 10;409(3):577-82. doi: 10.1016/j.bbrc.2011.05.052. Epub 2011 May 15. Biochem Biophys Res Commun. 2011. PMID: 21609713

6

Quantum dots-based molecular classification of breast cancer by quantitative spectroanalysis of hormone receptors and HER2.

Chen C, Sun SR, Gong YP, Qi CB, Peng CW, Yang XQ, Liu SP, Peng J, Zhu S, Hu MB, Pang DW, Li Y. Chen C, et al. Biomaterials. 2011 Oct;32(30):7592-9. doi: 10.1016/j.biomaterials.2011.06.029. Epub 2011 Jul 13. Biomaterials. 2011. PMID: 21745686

7

Quantum dot-based quantitative immunofluorescence detection and spectrum analysis of epidermal growth factor receptor in breast cancer tissue arrays.

Yang XQ, Chen C, Peng CW, Hou JX, Liu SP, Qi CB, Gong YP, Zhu XB, Pang DW, Li Y. Yang XQ, et al. Among authors: chen c. Int J Nanomedicine. 2011;6:2265-73. doi: 10.2147/IJN.S24161. Epub 2011 Oct 11. Int J Nanomedicine. 2011. PMID: 22072864 Free PMC article.

8

Tapping the potential of quantum dots for personalized oncology: current status and future perspectives.

Chen C, Peng J, Sun SR, Peng CW, Li Y, Pang DW. Chen C, et al. Nanomedicine (Lond). 2012 Mar;7(3):411-28. doi: 10.2217/nnm.12.9. Nanomedicine (Lond). 2012. PMID: 22385199 Review.

9

Lymph node ratio is more predictive than traditional lymph node stratification in lymph node positive invasive breast cancer.

Bai LS, Chen C, Gong YP, Wei W, Tu Y, Yao F, Li JJ, Wang LJ, Sun SR. Bai LS, et al. Among authors: chen c. Asian Pac J Cancer Prev. 2013;14(2):753-7. doi: 10.7314/apjcp.2013.14.2.753. Asian Pac J Cancer Prev. 2013. PMID: 23621232 Free article.

10

Differential phosphofructokinase-1 isoenzyme patterns associated with glycolytic efficiency in human breast cancer and paracancer tissues.

Wang G, Xu Z, Wang C, Yao F, Li J, Chen C, Sun S. Wang G, et al. Among authors: chen c. Oncol Lett. 2013 Dec;6(6):1701-1706. doi: 10.3892/ol.2013.1599. Epub 2013 Oct 1. Oncol Lett. 2013. PMID: 24260065 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91,686 results

Search Page

Filters